Skip to content
TTM Q2 '26TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25
Profitability
Gross margin52.1%+0.4pp51.6%+0.9pp50.7%+1.5pp49.2%+2.5pp46.7%+2.1pp
Operating margin-33.9%+0.5pp-34.4%+1.8pp-36.2%+3.1pp-39.3%+18.6pp-57.9%+5.3pp
Net margin-19.8%-0.3pp-19.6%+1.1pp-20.6%+2.9pp-23.5%+31.5pp-55%+4.8pp
Returns
Return on equity-18.2%-1.4pp-16.8%-0.4pp-16.4%+1.1pp-17.6%+20.6pp-38.2%-0.5pp
Return on invested capital-36.4%-0.4pp-36%+2.6pp-38.6%+1.9pp-40.5%+15.0pp-55.4%+0.7pp
Efficiency
Asset turnover0.6×0.0×0.6×0.0×0.6×0.0×0.6×0.0×0.5×0.0×
Liquidity
Current ratio2.7×-1.1×3.8×+0.1×3.6×-0.3×3.9×-0.6×4.5×-0.4×
Leverage
Debt-to-equity0.2×0.0×0.2×+0.1×0.2×0.0×0.2×0.0×0.2×0.0×
Per Share
Book value per share$7.38-1.2%$7.47-5.6%$7.91+1.1%$7.82+6.0%$7.38-4.3%
Valuation
Market capitalization$2.91B+50.2%$1.94B+14.2%$1.7B-20.9%$2.15B-8.3%$2.34B-15.1%
Price / sales7.1×+2.2×+0.4×4.5×-1.4×5.9×-0.8×6.7×-1.6×
Price / book6.4×+2.1×4.3×+0.7×3.6×-0.9×4.5×-0.8×5.3×-0.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Twist Bioscience Corporation's profit margins?
Twist Bioscience Corporation (TWST) runs a 52.1% gross margin and a -33.9% operating margin, with a -19.8% net margin.
Where do Twist Bioscience Corporation's ratios come from?
Every ratio is computed from Twist Bioscience Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.